| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net revenue | 183 | 338 | ||
| Cost of goods sold | 14 | 27 | ||
| Gross profit | 169 | 311 | ||
| Research and development | 1,850 | 1,037 | ||
| General and administrative | 1,898 | 1,030 | ||
| Total operating expenses | 3,748 | 2,067 | ||
| Loss from operations | -3,579 | -1,756 | ||
| Interest income | 107 | 45 | ||
| Interest expense | 0 | - | ||
| Other financing costs | 0 | - | ||
| Interest expense | - | 9 | ||
| Change in fair value of convertible notes | 0 | - | ||
| Change in fair value of warrants liability | 0 | -16 | ||
| Other financing costs | - | 298 | ||
| Change in fair value of convertible notes | - | 0 | ||
| Total other income (expense), net | 107 | -246 | ||
| Loss before provision for income taxes | -3,472 | -2,002 | ||
| Provision for income taxes | 0 | 0 | ||
| Net loss | -3,472 | -2,002 | ||
| Earnings per share, diluted | - | -0.18 | ||
| Weighted average number of shares outstanding, diluted | - | 11,329,517 | ||
| Net loss per share of common stock, basic and diluted (in dollars per share) | -0.13 | -0.18 | ||
| Weighted-average shares outstanding, basic and diluted (in shares) | 26,393,400 | 11,329,517 | ||
SeaStar Medical Holding Corp (ICUCW)
SeaStar Medical Holding Corp (ICUCW)